Security key
N69605108
Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (PHVS)
CUSIP: N69605108
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Ordinary Shares, par value Euro 0.12 per share
- Shares outstanding
- 65,237,679
- Total 13F shares
- 40,745,703
- Share change
- +11,678,601
- Total reported value
- $1,142,917,292
- Price per share
- $28.05
- Number of holders
- 36
- Value change
- +$327,949,428
- Number of buys
- 30
- Number of sells
- 7
Report period
Q4 2023
Institutions
36
Top holders
10
PHVS full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Pharvaris N.V. SEC filings
Pharvaris N.V. company facts
Broader feeds
Reporting periods
Holder history for CUSIP N69605108
Recent filing periods:
Top shareholders of PHVS - Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
7.3%
|
4,784,674
|
$99,856,146 | — | 30 Sep 2023 | |
| GENERAL ATLANTIC, L.P. |
13F
|
Company |
6.8%
|
4,406,252
|
$91,958,479 | — | 30 Sep 2023 | |
| venBio Partners LLC |
13F
|
Company |
6.5%
|
4,264,672
|
$89,003,705 | — | 30 Sep 2023 | |
| Foresite Capital Management IV, LLC |
13F
|
Company |
5.7%
|
3,743,450
|
$78,125,802 | — | 30 Sep 2023 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
5%
|
3,231,923
|
$67,450,233 | — | 30 Sep 2023 | |
| FMR LLC |
13F
|
Company |
4.9%
|
3,207,564
|
$66,941,861 | — | 30 Sep 2023 | |
| Venrock Adviser, LLC |
13F
|
Company |
2.4%
|
1,563,513
|
$32,630,516 | — | 30 Sep 2023 | |
| Cormorant Asset Management, LP |
13F
|
Company |
2.1%
|
1,361,460
|
$28,413,670 | — | 30 Sep 2023 | |
| Novo Holdings A/S |
13F
|
Company |
2%
|
1,329,325
|
$27,743,013 | — | 30 Sep 2023 | |
| 5AM Venture Management, LLC |
13F
|
Company |
0.9%
|
587,600
|
$12,263,212 | — | 30 Sep 2023 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.53%
|
343,975
|
$7,178,758 | — | 30 Sep 2023 | |
| Walleye Capital LLC |
13F
|
Company |
0.12%
|
81,017
|
$1,690,825 | — | 30 Sep 2023 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.06%
|
38,893
|
$811,697 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
33,697
|
$703,256 | — | 30 Sep 2023 | |
| Foresite Capital Management V, LLC |
13F
|
Company |
0.05%
|
33,142
|
$691,674 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
21,595
|
$450,687 | — | 30 Sep 2023 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.03%
|
17,553
|
$366,331 | — | 30 Sep 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.02%
|
11,900
|
$248,353 | — | 30 Sep 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
2,579
|
$53,824 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
2,268
|
$47,333 | — | 30 Sep 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
50
|
$1,044 | — | 30 Sep 2023 |
Institutional Holders of Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (PHVS) as of Q4 2023
As of 31 Dec 2023,
Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (PHVS) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,745,703 shares.
The largest 10 holders included
GENERAL ATLANTIC, L.P., FMR LLC, venBio Partners LLC, Foresite Capital Management IV, LLC, Bain Capital Life Sciences Investors, LLC, VIKING GLOBAL INVESTORS LP, VR Adviser, LLC, Cormorant Asset Management, LP, Novo Holdings A/S, and EcoR1 Capital, LLC.
This page lists
36
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
21
Q4 2023 holders
36
Holder diff
15
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.